{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:26:17Z","timestamp":1752549977675},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/bmt.2016.76","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T13:43:07Z","timestamp":1459777387000},"page":"928-932","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin\u2019s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)"],"prefix":"10.1038","volume":"51","author":[{"given":"A","family":"Stamatoullas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Brice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M S","family":"Gueye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mareschal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Bouabdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Nguyenquoc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Francois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Turlure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Monjanel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-H","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Biron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cornillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Belhadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Bonmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-S","family":"Dilhuydy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-L","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Peffault de Latour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Tilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,4]]},"reference":[{"key":"BFbmt201676_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.critrevonc.2008.12.007","volume":"71","author":"SJ Proctor","year":"2009","unstructured":"Proctor SJ, Wilkinson J, Sieniawski M . Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future. Crit Rev Oncol Hematol 2009; 71: 222\u2013232.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFbmt201676_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1182\/blood-2010-08-302604","volume":"119","author":"J Sjoberg","year":"2012","unstructured":"Sjoberg J, Halthur C, Kristinsson SY, Landgren O, Nygell UA, Dickman PW et al. Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973\u20132009. Blood 2012; 119: 990\u2013996.","journal-title":"Blood"},{"key":"BFbmt201676_CR3","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1200\/JCO.2013.49.8246","volume":"31","author":"B Boll","year":"2013","unstructured":"Boll B, Goergen H, Arndt N, Meissner J, Krause SW, Schnell R et al. Relapsed Hodgkin lymphoma in older patients: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 2013; 31: 4431\u20134437.","journal-title":"J Clin Oncol"},{"key":"BFbmt201676_CR4","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","volume":"359","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemo-sensitive Hodgkin\u2019s disease: a randomized trial. Lancet 2002; 359: 2065\u20132071.","journal-title":"Lancet"},{"key":"BFbmt201676_CR5","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1200\/JCO.2007.15.5887","volume":"26","author":"F Morschhauser","year":"2008","unstructured":"Morschhauser F, Brice P, Ferme C, Divine M, Salles G, Bouabdallah R et al. Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse\/refractory Hodgkin\u2019s Lymphoma: results of the prospective multicenter H96 trial by the GELA\/SFGM Study Group. J Clin Oncol 2008; 26: 5980\u20135987.","journal-title":"J Clin Oncol"},{"key":"BFbmt201676_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bmt.1702736","volume":"27","author":"J de la Rubia","year":"2001","unstructured":"de la Rubia J, Saavedra S, Sanz GF, Martin G, Moscardo F, Martinez J et al. Translant-related mortality in patients older than 60 years undergoing autologous hemopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 21\u201325.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201676_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3324\/haematol.13273","volume":"93","author":"E Jantunen","year":"2008","unstructured":"Jantunen E, Canals C, Rambaldi A, Ossenkoppele G, Allione B, Blaise D et al. Autologous stem cell transpalntation in elderly patients (\u2a7e60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow transplantation registry. Haematologica 2008; 93: 1837\u20131842.","journal-title":"Haematologica"},{"key":"BFbmt201676_CR8","first-page":"1339","volume":"46","author":"N Puig","year":"2011","unstructured":"Puig N, Pintilie M, Seshadri T, al-Farsi K, Franke N, Keating A et al. High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin\u2019s ymphoma. BMT 2011; 46: 1339\u20131344.","journal-title":"BMT"},{"key":"BFbmt201676_CR9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244\u20131253.","journal-title":"J Clin Oncol"},{"key":"BFbmt201676_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579\u2013586.","journal-title":"J Clin Oncol"},{"key":"BFbmt201676_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/oxfordjournals.annonc.a059242","volume":"6","author":"C Ferm\u00e9","year":"1995","unstructured":"Ferm\u00e9 C, Bastion Y, Lepage E, Berger F, Brice P, Morel P et al. The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease. Ann Oncol 1995; 6: 543\u2013549.","journal-title":"Ann Oncol"},{"key":"BFbmt201676_CR12","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3324\/haematol.2012.072090","volume":"98","author":"E Van Den Neste","year":"2013","unstructured":"Van Den Neste E, Casasnovas O, Andr\u00e9 M, Touati M, Senecal D, Edeline V et al. Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant. Haematologica 2013; 98: 1185\u20131195.","journal-title":"Haematologica"},{"key":"BFbmt201676_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373\u2013383.","journal-title":"J Chronic Dis"},{"key":"BFbmt201676_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/bjh.13419","volume":"170","author":"A Stamatoullas","year":"2015","unstructured":"Stamatoullas A, Brice P, Bouabdallah R, Mareschal S, Camus V, Rahal I et al. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly. Br J Haematol 2015; 170: 179\u2013184.","journal-title":"Br J Haematol"},{"key":"BFbmt201676_CR15","first-page":"221","volume":"20","author":"A Josting","year":"2002","unstructured":"Josting A, Franklin J, May M, Koch P, Beykirch MK, Heinz J et al. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. J Clin Oncol 2002; 20: 221\u2013230.","journal-title":"J Clin Oncol"},{"key":"BFbmt201676_CR16","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.bbmt.2013.09.018","volume":"19","author":"T Hahn","year":"2013","unstructured":"Hahn T, McCarthy PL, Carreras J, Zhang MJ, Lazarus HM, Laport GG et al. Simplified validated prognostic model for progression-free survival after autologous transplantation for Hodgkin lymphoma. Biol Blood Marrow Transplant 2013; 19: 1740\u20131744.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201676_CR17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.bbmt.2006.06.006","volume":"12","author":"NS Majhail","year":"2006","unstructured":"Majhail NS, Weisdorf DJ, Defor TE, Miller JS, McGlave PB, Slungaard A et al. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma. Biol Blood Marrow Transplant 2006; 12: 1065\u20131072.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201676_CR18","first-page":"98","volume":"3","author":"C Wheeler","year":"1997","unstructured":"Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M et al. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. Biol Blood Marrow Transplant 1997; 3: 98\u2013106.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201676_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3324\/haematol.2011.056051","volume":"97","author":"R Devillier","year":"2012","unstructured":"Devillier R, Coso D, Castagna L, Brenot Rossi I, Anastasia A, Chiti A et al. Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and\/or refractory Hodgkin's lymphoma responding to prior salvage therapy. Haematologica 2012; 97: 1073\u20131079.","journal-title":"Haematologica"},{"key":"BFbmt201676_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbmt.2013.04.027","volume":"19","author":"PL McCarthy Jr","year":"2013","unstructured":"McCarthy PL Jr, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G et al. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995\u20132005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. Biol Blood Marrow Transplant 2013; 19: 1116\u20131123.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201676_CR21","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.bbmt.2014.08.019","volume":"20","author":"PB Dahi","year":"2014","unstructured":"Dahi PB, Tamari R, Devlin SM, Maloy M, Bhatt V, Scordo M et al. Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2014; 20: 2004\u20132009.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201676_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1182\/blood-2014-08-595801","volume":"125","author":"AK Gopal","year":"2015","unstructured":"Gopal AK, Chen R, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ et al. Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. Blood 2015; 125: 1236\u20131243.","journal-title":"Blood"},{"key":"BFbmt201676_CR23","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(15)60165-9","volume":"385","author":"CH Moskowitz","year":"2015","unstructured":"Moskowitz CH, Nademanee A, Masszi T, Agura E, Holowiecki J, Abidi MH et al. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2015; 385: 1853\u20131862.","journal-title":"Lancet"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201676","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:16:03Z","timestamp":1648062963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,4]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFbmt201676"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.76","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,4]]},"assertion":[{"value":"17 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}